These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6543124)

  • 21. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart.
    Groschner K; Lindner W; Schnedl H; Kukovetz WR
    Br J Pharmacol; 1991 Mar; 102(3):669-74. PubMed ID: 1364837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The multiple modes of action of propafenone.
    Dukes ID; Vaughan Williams EM
    Eur Heart J; 1984 Feb; 5(2):115-25. PubMed ID: 6144546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
    Seipel L; Breithardt G; Both A
    Z Kardiol; 1975 Aug; 64(8):731-40. PubMed ID: 1163095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of etafenone and antiarrhythmic drugs on Na and Ca channels of guinea pig atrial muscle.
    Hashimoto K; Satoh H; Imai S
    J Cardiovasc Pharmacol; 1979; 1(5):561-70. PubMed ID: 94412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiological effects of 5-hydroxypropafenone on guinea pig ventricular muscle fibers.
    Valenzuela C; Delgado C; Tamargo J
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):523-9. PubMed ID: 2447400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
    Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developmental electrophysiologic effects of propafenone and 5-hydroxypropafenone on the canine cardiac Purkinje fiber.
    Case CL; Ravin RR; Maheshwari R; Gillette PC; Hewett KW
    Dev Pharmacol Ther; 1991; 17(1-2):24-34. PubMed ID: 1811919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of propafenone on left ventricular function in patients with myocardial infarct].
    Arrigo F; Bonanno N; Baldari S; Giannetto M; Luzza F
    Cardiologia; 1985 May; 30(5):379-85. PubMed ID: 3833350
    [No Abstract]   [Full Text] [Related]  

  • 29. Electromechanical effects of newly synthetized propafenone derivatives on isolated guinea-pig heart muscle preparations.
    Studenik C; Lemmens-Gruber R; Heistracher P; Ecker G; Maxl A; Fleischhacker W
    Arzneimittelforschung; 1996 Feb; 46(2):134-8. PubMed ID: 8720301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BW A256C, a chemically novel class 1 antiarrhythmic agent. A comparison of in vitro and in vivo activity with other class 1 antiarrhythmic agents.
    Allan G; Donoghue S; Follenfant MJ; Sawyer DA
    Br J Pharmacol; 1986 Jun; 88(2):333-43. PubMed ID: 3730698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiologic, antiarrhythmic and hemodynamic effects of transcainide.
    Carmeliet E; Janssen PA; Heykants J; Niemegeers CJ; Remeysen P; Van De Water A; Van Gerven W; Wauquier A; Xhonneux R
    Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):272-90. PubMed ID: 3632145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic and hemodynamic effects of prifuroline.
    Benharkate M; Plassard G; Legeai J; Worcel M
    Arzneimittelforschung; 1986 Dec; 36(12):1761-7. PubMed ID: 3566836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of glucuronides of propafenone and 5-hydroxypropafenone by Sepharose-bound uridine 5'-diphosphoglucuronyltransferase.
    Neidlein R; Wu M; Hege HG
    Arzneimittelforschung; 1988 Sep; 38(9):1257-62. PubMed ID: 3146983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes.
    Slawsky MT; Castle NA
    J Pharmacol Exp Ther; 1994 Apr; 269(1):66-74. PubMed ID: 8169853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of some cardiodepressant drugs on the histamine-induced restoration of contractility in potassium-depolarized heart preparations.
    Mantelli L; Manzini S; Mugelli A; Ledda F
    Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):99-108. PubMed ID: 7337497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.